Mr. Arun Nayyar reports

VANC PHARMACEUTICALS PLACES INVENTORY PURCHASE ORDER FOR 30 GENERIC MOLECULES

Vanc Pharmaceuticals Inc. has placed inventory purchase orders for 30 generic molecules with leading generic pharmaceutical manufacturing partners. The company expects delivery of the products in the second quarter of 2015.

"We are excited to take this important step towards commercialization and look forward to launching sales in Q2 2015. These 30 molecules represent best-selling generics in the Canadian market and our aim to provide Canadians with quality and cost-effective products is well served by them," said Arun Nayyar, chief executive officer of Vanc. "Our initial marketing and outreach activities with select pharmacy customers in Western Canada have been positive and we look forward to working with our partners."

The 30 generic molecules include those for both acute and chronic indications. The company will provide additional updates over the coming months.

We seek Safe Harbor.